APO Research
Talk to an analyst

APO RESEARCH · REPORT

Receptor Tyrosine Protein Kinase ERBB 3

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Receptor Tyrosine Protein Kinase ERBB 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025195 pages

Choose your research edition.

Industry ResearchReceptor Tyrosine Protein Kinase ERBB 3 Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Receptor Tyrosine Protein Kinase ERBB 3 Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Receptor Tyrosine Protein Kinase ERBB 3 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Receptor Tyrosine Protein Kinase ERBB 3 include Novartis AG, GlaxoSmithKline Plc, AstraZeneca Plc, Takis S.r.l., Symphogen A/S, Sorrento Therapeutics, Inc., Sihuan Pharmaceutical Holdings Group Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Merus B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Receptor Tyrosine Protein Kinase ERBB 3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Receptor Tyrosine Protein Kinase ERBB 3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Receptor Tyrosine Protein Kinase ERBB 3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Receptor Tyrosine Protein Kinase ERBB 3 market size, projected growth trends, production technologies, key applications, and end-use industries.

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Company

Novartis AG

GlaxoSmithKline Plc

AstraZeneca Plc

Takis S.r.l.

Symphogen A/S

Sorrento Therapeutics, Inc.

Sihuan Pharmaceutical Holdings Group Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Merus B.V.

Merrimack Pharmaceuticals, Inc.

Kolltan Pharmaceuticals, Inc.

ImmunoGen, Inc.

Hanmi Pharmaceuticals, Co. Ltd.

GamaMabs Pharma S.A.

F. Hoffmann-La Roche Ltd.

Etubics Corporation

AVEO Pharmaceuticals, Inc.

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type

BA-0702

CDX-3379

Elgemtumab

ETBX-031

Others

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application

Non-Small Cell Carcinoma

Solid Tumor

Melanoma

Colorectal Cancer

Others

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Receptor Tyrosine Protein Kinase ERBB 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Receptor Tyrosine Protein Kinase ERBB 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Receptor Tyrosine Protein Kinase ERBB 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Receptor Tyrosine Protein Kinase ERBB 3 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Receptor Tyrosine Protein Kinase ERBB 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Receptor Tyrosine Protein Kinase ERBB 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends Table 2. Receptor Tyrosine Protein Kinase ERBB 3 Industry Drivers Table 3. Receptor Tyrosine Protein Kinase ERBB 3 Industry Opportunities and Challenges Table 4. Receptor Tyrosine Protein Kinase ERBB 3 Industry Restraints Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers, Product Type & Application Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BA-0702 Table 17. Major Manufacturers of CDX-3379 Table 18. Major Manufacturers of Elgemtumab Table 19. Major Manufacturers of ETBX-031 Table 20. Major Manufacturers of Others Table 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2027-2032) & (K Units) Table 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2021-2026) Table 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2027-2032) Table 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2021-2026) & (K Units) Table 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2027-2032) & (K Units) Table 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2021-2026) Table 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Non-Small Cell Carcinoma Table 32. Major Manufacturers of Solid Tumor Table 33. Major Manufacturers of Melanoma Table 34. Major Manufacturers of Colorectal Cancer Table 35. Major Manufacturers of Others Table 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2027-2032) & (K Units) Table 39. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2021-2026) Table 40. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2027-2032) Table 41. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2021-2026) & (K Units) Table 43. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2027-2032) & (K Units) Table 44. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2021-2026) Table 45. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2027-2032) Table 46. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021-2026) & (K Units) Table 48. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2021-2026) Table 49. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 53. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2027-2032) & (K Units) Table 54. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 56. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2027-2032) & (K Units) Table 63. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2021-2026) Table 67. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2027-2032) Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 72. Novartis AG Recent Development Table 73. GlaxoSmithKline Plc Company Information Table 74. GlaxoSmithKline Plc Business Overview Table 75. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 77. GlaxoSmithKline Plc Recent Development Table 78. AstraZeneca Plc Company Information Table 79. AstraZeneca Plc Business Overview Table 80. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 82. AstraZeneca Plc Recent Development Table 83. Takis S.r.l. Company Information Table 84. Takis S.r.l. Business Overview Table 85. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 87. Takis S.r.l. Recent Development Table 88. Symphogen A/S Company Information Table 89. Symphogen A/S Business Overview Table 90. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 92. Symphogen A/S Recent Development Table 93. Sorrento Therapeutics, Inc. Company Information Table 94. Sorrento Therapeutics, Inc. Business Overview Table 95. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 97. Sorrento Therapeutics, Inc. Recent Development Table 98. Sihuan Pharmaceutical Holdings Group Ltd. Company Information Table 99. Sihuan Pharmaceutical Holdings Group Ltd. Business Overview Table 100. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 102. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development Table 103. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Information Table 104. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview Table 105. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 107. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development Table 108. Merus B.V. Company Information Table 109. Merus B.V. Business Overview Table 110. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 112. Merus B.V. Recent Development Table 113. Merrimack Pharmaceuticals, Inc. Company Information Table 114. Merrimack Pharmaceuticals, Inc. Business Overview Table 115. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 117. Merrimack Pharmaceuticals, Inc. Recent Development Table 118. Kolltan Pharmaceuticals, Inc. Company Information Table 119. Kolltan Pharmaceuticals, Inc. Business Overview Table 120. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 122. Kolltan Pharmaceuticals, Inc. Recent Development Table 123. ImmunoGen, Inc. Company Information Table 124. ImmunoGen, Inc. Business Overview Table 125. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 127. ImmunoGen, Inc. Recent Development Table 128. Hanmi Pharmaceuticals, Co. Ltd. Company Information Table 129. Hanmi Pharmaceuticals, Co. Ltd. Business Overview Table 130. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 132. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 133. GamaMabs Pharma S.A. Company Information Table 134. GamaMabs Pharma S.A. Business Overview Table 135. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 137. GamaMabs Pharma S.A. Recent Development Table 138. F. Hoffmann-La Roche Ltd. Company Information Table 139. F. Hoffmann-La Roche Ltd. Business Overview Table 140. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 142. F. Hoffmann-La Roche Ltd. Recent Development Table 143. Etubics Corporation Company Information Table 144. Etubics Corporation Business Overview Table 145. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 147. Etubics Corporation Recent Development Table 148. AVEO Pharmaceuticals, Inc. Company Information Table 149. AVEO Pharmaceuticals, Inc. Business Overview Table 150. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 152. AVEO Pharmaceuticals, Inc. Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List Table 156. Receptor Tyrosine Protein Kinase ERBB 3 Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Product Image Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (2021-2032) & (US$ Million) Figure 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (2021-2032) & (K Units) Figure 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BA-0702 Image Figure 9. CDX-3379 Image Figure 10. Elgemtumab Image Figure 11. ETBX-031 Image Figure 12. Others Image Figure 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2021-2032) Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2021-2032) Figure 19. Non-Small Cell Carcinoma Image Figure 20. Solid Tumor Image Figure 21. Melanoma Image Figure 22. Colorectal Cancer Image Figure 23. Others Image Figure 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2021-2032) Figure 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2021-2032) Figure 30. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2032) Figure 32. U.S. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2032) Figure 37. Germany Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2032) Figure 44. China Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2032) Figure 52. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032) & (US$ Million) Figure 63. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Receptor Tyrosine Protein Kinase ERBB 3 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BA-0702
  • CDX-3379
  • Elgemtumab
  • ETBX-031
  • Others
Applications
  • Non-Small Cell Carcinoma
  • Solid Tumor
  • Melanoma
  • Colorectal Cancer
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Takis S.r.l.
  • Symphogen A/S
  • Sorrento Therapeutics, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Merus B.V.
  • Merrimack Pharmaceuticals, Inc.
  • Kolltan Pharmaceuticals, Inc.
  • ImmunoGen, Inc.
  • Hanmi Pharmaceuticals, Co. Ltd.
  • GamaMabs Pharma S.A.
  • F. Hoffmann-La Roche Ltd.
  • Etubics Corporation
  • AVEO Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Dynamics
  1. 2.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends
  2. 2.2 Receptor Tyrosine Protein Kinase ERBB 3 Industry Drivers
  3. 2.3 Receptor Tyrosine Protein Kinase ERBB 3 Industry Opportunities and Challenges
  4. 2.4 Receptor Tyrosine Protein Kinase ERBB 3 Industry Restraints
3 Receptor Tyrosine Protein Kinase ERBB 3 Market by Manufacturers
  1. 3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers, Product Type & Application
  7. 3.7 Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Receptor Tyrosine Protein Kinase ERBB 3 Tier 1, Tier 2, and Tier 3
4 Receptor Tyrosine Protein Kinase ERBB 3 Market by Type
  1. 4.1 Receptor Tyrosine Protein Kinase ERBB 3 Type Introduction
  2. 4.1.1 BA-0702
  3. 4.1.2 CDX-3379
  4. 4.1.3 Elgemtumab
  5. 4.1.4 ETBX-031
  6. 4.1.5 Others
  7. 4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type
  8. 4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2032)
  10. 4.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type
  12. 4.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2021-2032)
  14. 4.3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2021-2032)
5 Receptor Tyrosine Protein Kinase ERBB 3 Market by Application
  1. 5.1 Receptor Tyrosine Protein Kinase ERBB 3 Application Introduction
  2. 5.1.1 Non-Small Cell Carcinoma
  3. 5.1.2 Solid Tumor
  4. 5.1.3 Melanoma
  5. 5.1.4 Colorectal Cancer
  6. 5.1.5 Others
  7. 5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application
  8. 5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2032)
  10. 5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application
  12. 5.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2021-2032)
  14. 5.3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2021-2032)
6 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region
  1. 6.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021-2032)
  3. 6.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021-2026)
  4. 6.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region
  1. 7.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region
  2. 7.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2021-2026)
  4. 7.1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2027-2032)
  5. 7.1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032)
  8. 7.2.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032)
  11. 7.3.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 AstraZeneca Plc
  14. 8.3.1 AstraZeneca Plc Company Information
  15. 8.3.2 AstraZeneca Plc Business Overview
  16. 8.3.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  18. 8.3.5 AstraZeneca Plc Recent Developments
  19. 8.4 Takis S.r.l.
  20. 8.4.1 Takis S.r.l. Company Information
  21. 8.4.2 Takis S.r.l. Business Overview
  22. 8.4.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  24. 8.4.5 Takis S.r.l. Recent Developments
  25. 8.5 Symphogen A/S
  26. 8.5.1 Symphogen A/S Company Information
  27. 8.5.2 Symphogen A/S Business Overview
  28. 8.5.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  30. 8.5.5 Symphogen A/S Recent Developments
  31. 8.6 Sorrento Therapeutics, Inc.
  32. 8.6.1 Sorrento Therapeutics, Inc. Company Information
  33. 8.6.2 Sorrento Therapeutics, Inc. Business Overview
  34. 8.6.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  36. 8.6.5 Sorrento Therapeutics, Inc. Recent Developments
  37. 8.7 Sihuan Pharmaceutical Holdings Group Ltd.
  38. 8.7.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
  39. 8.7.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
  40. 8.7.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  42. 8.7.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
  43. 8.8 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  44. 8.8.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Information
  45. 8.8.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview
  46. 8.8.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  48. 8.8.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments
  49. 8.9 Merus B.V.
  50. 8.9.1 Merus B.V. Company Information
  51. 8.9.2 Merus B.V. Business Overview
  52. 8.9.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  54. 8.9.5 Merus B.V. Recent Developments
  55. 8.10 Merrimack Pharmaceuticals, Inc.
  56. 8.10.1 Merrimack Pharmaceuticals, Inc. Company Information
  57. 8.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
  58. 8.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  60. 8.10.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  61. 8.11 Kolltan Pharmaceuticals, Inc.
  62. 8.11.1 Kolltan Pharmaceuticals, Inc. Company Information
  63. 8.11.2 Kolltan Pharmaceuticals, Inc. Business Overview
  64. 8.11.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  66. 8.11.5 Kolltan Pharmaceuticals, Inc. Recent Developments
  67. 8.12 ImmunoGen, Inc.
  68. 8.12.1 ImmunoGen, Inc. Company Information
  69. 8.12.2 ImmunoGen, Inc. Business Overview
  70. 8.12.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  72. 8.12.5 ImmunoGen, Inc. Recent Developments
  73. 8.13 Hanmi Pharmaceuticals, Co. Ltd.
  74. 8.13.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  75. 8.13.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
  76. 8.13.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  78. 8.13.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
  79. 8.14 GamaMabs Pharma S.A.
  80. 8.14.1 GamaMabs Pharma S.A. Company Information
  81. 8.14.2 GamaMabs Pharma S.A. Business Overview
  82. 8.14.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  84. 8.14.5 GamaMabs Pharma S.A. Recent Developments
  85. 8.15 F. Hoffmann-La Roche Ltd.
  86. 8.15.1 F. Hoffmann-La Roche Ltd. Company Information
  87. 8.15.2 F. Hoffmann-La Roche Ltd. Business Overview
  88. 8.15.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  90. 8.15.5 F. Hoffmann-La Roche Ltd. Recent Developments
  91. 8.16 Etubics Corporation
  92. 8.16.1 Etubics Corporation Company Information
  93. 8.16.2 Etubics Corporation Business Overview
  94. 8.16.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  96. 8.16.5 Etubics Corporation Recent Developments
  97. 8.17 AVEO Pharmaceuticals, Inc.
  98. 8.17.1 AVEO Pharmaceuticals, Inc. Company Information
  99. 8.17.2 AVEO Pharmaceuticals, Inc. Business Overview
  100. 8.17.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  102. 8.17.5 AVEO Pharmaceuticals, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Receptor Tyrosine Protein Kinase ERBB 3 Value Chain Analysis
  2. 9.1.1 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process
  6. 9.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors
  9. 9.2.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst